OUR PRODUCTS
BioAge
BioAge determines a person’s biological age, which can give an indication of their overall health, by looking at vascular, metabolic, inflammatory and lifestyle indicators present in the retinal image.
Expand BioAge Regulatory information
BioAge has varying regulatory statuses depending on the region and is not yet cleared for sale in all markets. Please refer to the BioAge page or contact our support for more information and availability in your market.
CLAiR
Future of Cardiovascular risk screening
CLAiR unlocks the power of retinal cameras to enable them to deliver real-time, non invasive cardiovascular risk assessments.
OUR SCIENCE
Leaders in AI clinical research
Toku specializes in developing non-invasive, AI-powered diagnostic and screening tools using retinal imaging to measure cardiovascular and other health risk factors.
Our Technology is
Cost-effective
Non-invasive
Backed by science
Revolutionary
With an AI Engine ahead of the curve
1,324,857
Eye images and still counting!
At Toku, our commitment to quality is unwavering.
As an ISO 13485 certified company, you can trust that our products are manufactured with the highest standards of quality and safety in mind.
Our worldwide partners & investors
As seen in
OUR VISION
If you can see the future, you can change it.
We believe every person in the world should have access to early diagnosis of health conditions before it’s too late.
Toku’s CEO Ehsan Vaghefi’s father’s experience with preventable blindness inspired a lifelong commitment to fighting preventable diseases.
OUR VISION
If you can see the future, you can change it.
We believe every person in the world should have access to early diagnosis of health conditions before it’s too late.
Toku’s CEO Ehsan Vaghefi’s father’s experience with preventable blindness inspired a lifelong commitment to fighting preventable diseases.
Play to see how we’re helping transform healthcare or click below to meet our team.
